PMID: 10866434

Super M
CFTR and disease: implications for drug development.
Lancet. 2000 May 27;355(9218):1840-2., [PubMed]
Sentences
No. Mutations Sentence Comment
53 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 10866434:53:166
status: NEW
view ABCC7 p.Trp1282* details
 Now M Wilschanski and colleagues14 have found that gentamicin corrects the intranasal electronegativity in cystic-fibrosis patients with the stop mutations including W1282X, which occurs in 60% of cystic-fibrosis patients of Ashkenazi origin. Login to comment